Last Updated: January 19, 2026
REEM PHARMACEUTICAL
Aliases
REEM PHARMACEUTICAL, S.A.R.L.; REEM PHARMACEUTICAL, LLC; REEM PHARMACEUTICAL, SAL
Address
Kalim Bechara Building, 2nd floor, Trabolsi Street, Badaro, Beirut, Lebanon
Other Information
SDN
Date of listing
2017-02-03
Program information
Authority
US
Program
Iranian Financial Sanctions Regulations, 31 CFR Part 561
Regime
OFAC country specific
Target State
Iran
Measures
Blocking Property, Trade sanctions
Sanctions Portfolio
• https://ofac.treasury.gov/faqs/topic/1551
Official Information
On August 16, 2010, OFAC issued the Iranian Financial Sanctions Regulations, 31 CFR part 561 (75 FR 49836, August 16, 2010) (IFSR) to implement provisions of the Comprehensive Iran Sanctions, Accountability, and Divestment Act of 2010 (Pub. L. 111–195) (22 U.S.C. 8501–8551). Since then, OFAC has amended the IFSR several times.
Additional Details
SDN
Program URL
https://www.ecfr.gov/current/title-31/subtitle-B/chapter-V/part-561